Bavarian Nordic — December 2023
-
Har markedet fået en nys om, at der er en ordre på vej?
-
Shorts stadig på 7,94%...
-
TBE ACIP anbefalinger. Skal Pfeizer ha’ markedet alene i USA? https://www.cdc.gov/mmwr/volumes/72/rr/rr7205a1.htm
-
Faldt over denne Bava-vaccine-hjemmeside... https://bnvaccines.com/ Var faktisk ikke klar over, at de havde en 6 sproget hjemmeside om deres vacciner... Jeg har tidligere kun frekventeret denne https://www.bavarian-nordic.com/
-
@Finansmanden i går 05:05 (!) Kan undre, at det er via LMS, at det "kundgøres", at efterspørgslen efter Rabipur ikke kan imødekommes i en 6-ugers periode... Og ærgerligt, at der igen er udfordringer med productionskapacitet...
-
@WorkTrader 08:47 DRC har længe hævdet, at de ikke er "tilbudt" vaccinen, mens BN har sagt, at de ikke har modtaget forespørgsel fra DRC. På tide, at WHO/BN fortæller, at vaccinerne har ligget klar i et år, men at det er Præsidenten/regeringen i Congo, der spærrer vejen ved ikke at "rekvirere" vaccinen, hvilket er et krav for at kunne "tilbyde" vaccinen til borgerne. Vi har diskuteret det før, I know, men fortsat sørgeligt for Congoleserne, øvrige afrikanske lande + verdenssamfundet.
-
EDCD om mpox clade I d.d. Essensen er, at det p.t. ikke udgør nogen væsentlig risiko for Europa's MSM miljø eller befolkningen som helhed.
Den korte https://www.ecdc.europa.eu/en/news-events/ecdc-assesses-risk-associated-ongoing-mpox-epidemic-democratic-republic-congo Den lange https://www.ecdc.europa.eu/sites/default/files/documents/TAB-Implications-mpox-drc.pdf -
Godmorgen.

-
Shortpositioner på danske aktier onsdag d. 6. december 2023 https://www.proinvestor.com/boards/117079
-
Cupcake 23:23 - mange tak. Fra den lange … Building capacity for contact tracing, diagnosis and sequencing, and vaccination are WHO priorities in DRC to support public health authorities' control efforts.
-
Mon ikke at vi rammer 175 i dag for så at gå ned igen.
-
Godmorgen. 23.05..enig @Cupcake - 'Stigma, regulatory hurdles and competing disease outbreaks' er forklaringen https://www.reuters.com/business/healthcare-pharmaceuticals/stigma-regulatory-barriers-delay-mpox-response-country-that-needs-it-most-2023-12-05/?utm_source=twitter&utm_medium=Social
-
“Bavarian Nordic is willing to support the current situation in the DRC and monitoring it closely,” chief executive Paul Chaplin said in a statement. “JYNNEOS is not approved in the DRC, or any other country in Africa, so the issue of liability/indemnification has to be resolved whether doses are sold or donated.” https://www.washingtonpost.com/health/2023/12/06/mpox-monkeypox-congo-who-vaccines/ - mon ikke der snart sker noget her...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind